Delivery Order SPE2DR25D1104-SPE2DR26FK522
Award Date 11/28/25
Potential Completion Date 12/1/25
Potential Value $47K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $16,612.59 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units). This firm fixed-price delivery order, awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a non-competitive set-aside award. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $27,989.79 to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg on December 3, 2025, with completion scheduled for December 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $12,991.41 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Xifaxan 550 mg tablets (60-count) with a ceiling value of $29,052.26. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by November 26, 2025, with performance taking place at the contractor's Conshohocken facility....
- The Defense Logistics Agency awarded a $35,933.54 delivery order to AmerisourceBergen Drug Corp for Xifaxan 550 mg tablets (60-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a competitive delivery order valued at $4,651.90 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This order will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, using firm fixed pricing with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $12,163.66 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 17, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in the federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,286.26 to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply agreement valued through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, with a ceiling value of $2,541.29. The contract calls for the delivery of Xifaxan 550 mg tablets (60-count) with a completion deadline of June 3, 2025. This is a non-set-aside, competitively awarded delivery order representing a single pharmaceutical procurement transaction. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $35,629.10 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for...